Free Trial

Tiziana Life Sciences (NASDAQ:TLSA) Trading Down 3.7% - Here's What Happened

Tiziana Life Sciences logo with Medical background

Tiziana Life Sciences Ltd (NASDAQ:TLSA - Get Free Report) shares fell 3.7% during trading on Tuesday . The company traded as low as $0.91 and last traded at $0.91. 61,647 shares changed hands during mid-day trading, a decline of 70% from the average session volume of 208,430 shares. The stock had previously closed at $0.95.

Tiziana Life Sciences Price Performance

The business has a fifty day moving average of $0.95 and a 200 day moving average of $0.96.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Tiziana Life Sciences stock. Zhang Financial LLC boosted its holdings in Tiziana Life Sciences Ltd (NASDAQ:TLSA - Free Report) by 24.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 69,387 shares of the company's stock after acquiring an additional 13,500 shares during the period. Zhang Financial LLC owned 0.07% of Tiziana Life Sciences worth $67,000 at the end of the most recent reporting period.

Tiziana Life Sciences Company Profile

(Get Free Report)

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases.

Read More

Should you invest $1,000 in Tiziana Life Sciences right now?

Before you consider Tiziana Life Sciences, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tiziana Life Sciences wasn't on the list.

While Tiziana Life Sciences currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines